A detailed history of Solutions 4 Wealth, LTD transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Solutions 4 Wealth, LTD holds 36,003 shares of GALT stock, worth $97,928. This represents 0.19% of its overall portfolio holdings.

Number of Shares
36,003
Previous 36,085 0.23%
Holding current value
$97,928
Previous $81.6 Million 21.4%
% of portfolio
0.19%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.04 - $2.86 $167 - $234
-82 Reduced 0.23%
36,003 $99 Million
Q4 2023

Feb 06, 2024

BUY
$1.6 - $2.18 $57,736 - $78,665
36,085 New
36,085 $59.9 Million

Others Institutions Holding GALT

About GALECTIN THERAPEUTICS INC


  • Ticker GALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,426,000
  • Market Cap $162M
  • Description
  • Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...
More about GALT
Track This Portfolio

Track Solutions 4 Wealth, LTD Portfolio

Follow Solutions 4 Wealth, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Solutions 4 Wealth, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Solutions 4 Wealth, LTD with notifications on news.